Shuttle Pharmaceuticals Holdings, Inc.
SHPH
$0.45
-$0.03-6.55%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -14.36% | 72.00% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -20.49% | 23.00% | |||
| Operating Income | 20.49% | -23.00% | |||
| Income Before Tax | 17.68% | -11.40% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 17.68% | -11.40% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 17.68% | -11.40% | |||
| EBIT | 20.49% | -23.00% | |||
| EBITDA | 11.34% | -10.30% | |||
| EPS Basic | 54.68% | 10.17% | |||
| Normalized Basic EPS | 59.93% | -1.60% | |||
| EPS Diluted | 54.79% | 9.96% | |||
| Normalized Diluted EPS | 59.93% | -1.60% | |||
| Average Basic Shares Outstanding | 81.65% | 24.01% | |||
| Average Diluted Shares Outstanding | 81.65% | 24.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||